Insider Trading: Furiex Pharmaceuticals Inc (FURX.O)
FURX.O on Nasdaq
35.63USD
19 Jun 2013
35.63USD
19 Jun 2013
Price Change (% chg)
$-1.30 (-3.52%)
$-1.30 (-3.52%)
Prev Close
$36.93
$36.93
Open
$36.58
$36.58
Day's High
$36.88
$36.88
Day's Low
$35.53
$35.53
Volume
49,225
49,225
Avg. Vol
67,767
67,767
52-wk High
$42.30
$42.30
52-wk Low
$17.50
$17.50
| ESHELMAN FREDRIC N | Options Exercised: 0 | ||
| Trade Date: | Tuesday, 13 Mar 2012 | Price: | 23.75 |
| Title: | Director and Beneficial Owner | Shares Held: | 2,289,553 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 45,307 |
Institutional Holders
| % Shares Owned: | 59.12% |
| # of Holders: | 127 |
| Total Shares Held: | 5,979,432 |
| 3 Mo. Net Change: | 420,022 |
| # New Positions: | 28 |
| # Closed Positions: | 9 |
| # Increased Positions: | 60 |
| # Reduced Positions: | 44 |
| # Net Buyers: | 16 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Fredric Eshelman |
63 | 2009 | Chairman of the Board |
June Almenoff |
56 | 2012 | President, Chief Medical Officer, Principal Executive Officer, Director |
Marshall Woodworth |
55 | 2010 | Chief Financial Officer, Treasurer, Assistant Secretary |
Paul Covington |
57 | 2010 | Senior Vice President - Clinical Development and Operations |
Gail McIntyre |
50 | 2010 | Senior Vice President - Research |
Peter Corr |
2010 | Independent Director | |
Wendy Dixon |
56 | 2010 | Independent Director |
Stephen Kaldor |
50 | 2010 | Independent Director |
Robert Ruscher |
52 | 2010 | Independent Director |
Sailash Patel |
Vice President - Strategic Development |

